Status:
COMPLETED
Increasing African Immigrant Women's Participation in Breast Cancer Screening
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Breast Cancer
Eligibility:
All Genders
18-74 years
Phase:
NA
Brief Summary
New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor health care access ...
Detailed Description
The goal of Aim 1 is to collect formative data via a mixed methods approach and use those results to culturally adapt the Witness Project for African immigrant populations. Cultural adaptation will fo...
Eligibility Criteria
Inclusion
- AIM 1:
- Inclusion criteria in-depth interviews with leaders:
- ≥ 18 years of age
- Stakeholder/gatekeeper in the African immigrant community, and read and speak English or French.
- Inclusion criteria for In-depth Interviews and Quantitative Surveys:
- Women 40 years of age or older;
- Born in Africa;
- Speak English or French.
- Exclusion Criteria
- \<18 years of age
- Cannot read and speak English or French
- AIM 2:
- Inclusion Criteria
- ≥ 38 years of age
- Women born in Africa, and read and speak English or French.
- Exclusion Criteria
- \<38 years of age
- Cannot read and speak English or French
Exclusion
Key Trial Info
Start Date :
February 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2023
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT04450264
Start Date
February 5 2020
End Date
June 29 2023
Last Update
December 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029